The best stock screener for US stocks in 2026 is Finviz for investors who only screen the US market — it has the deepest filter set, the fastest interface, and a free no-account tier with over 60 fundamental and technical filters. For investors who also screen European and Canadian equities alongside US stocks in a single tool, ScreenerHero covers all three markets with reliable fundamental data at a lower monthly price than Finviz Elite.
Last updated: July 2026.
What makes a good US stock screener?
The US equity market spans roughly 6,000 listed companies across NYSE, NASDAQ, and NYSE American. A good US stock screener needs to handle the full universe — not just S&P 500 components — with:
- Reliable fundamental data for small and mid-caps. Many US small caps below $500M market cap have inconsistent data in screeners that rely on a single data provider. P/E, EV/EBITDA, and margin data should be available and up to date for the full NYSE and NASDAQ universe.
- At least 30–40 fundamental filters. The minimum useful set: market cap, P/E, P/B, EV/EBITDA, revenue growth, profit margin, ROE, dividend yield, debt-to-equity, and beta. Professional-grade screeners add insider ownership, short float, institutional ownership, and earnings estimate revisions.
- Fast filter updates. Results should refresh in under two seconds. A screener that requires page reloads for each filter change is unusable for iterative screening.
- A usable free tier. The best US screeners have free tiers that don't degrade the core screening experience. Requiring an account or hiding core filters behind a paywall is a red flag.
- Technical overlays. US investors more frequently combine fundamental and technical screening than European investors. RSI, moving averages, chart patterns alongside fundamental filters are a genuine workflow requirement for many US investors.
The 7 main US stock screeners compared
1. Finviz — Best for pure US fundamental screening
Coverage: US equities only — NYSE, NASDAQ, NYSE American, OTC markets. Small number of European ADRs listed in the US. No direct coverage of European or Canadian exchanges.
Filters: 65+ filters including fundamental (P/E, P/B, EV/EBITDA, ROE, margins, debt, dividend yield), technical (RSI, moving averages, 52-week range, chart patterns), and ownership (insider ownership, institutional ownership, short float). The most comprehensive US filter set of any screener.
Free tier: Full fundamental screener, no account required. Data is 15-minute delayed on the free tier. Results include a stock table, map view, and news feed.
Paid plan: $39.50/month Elite · $299.50/year (~$25/month). Elite adds real-time data, backtesting, email alerts, and an advanced chart mode.
Best for: US equity investors whose workflow is entirely within the US market. Nothing surpasses Finviz for filtering the NYSE and NASDAQ universe by fundamental and technical criteria simultaneously.
Limitations: No European or Canadian coverage. Investors who screen across markets need a separate tool for non-US equities.
2. ScreenerHero — Best for US + European + Canadian screening in one tool
Coverage: US (NYSE, NASDAQ), Canada (TSX, TSXV), and all major European exchanges — XETRA, Euronext Paris, BME, Borsa Italiana, Euronext Amsterdam, plus alternative markets (Euronext Growth, Nasdaq First North, EGM Milan, GPW NewConnect). Coverage for US stocks is equivalent to Finviz for fundamental criteria; adds international coverage Finviz lacks entirely.
Filters: P/E, P/B, EV/EBITDA, FCF yield, ROE, ROIC, revenue growth, profit margin, dividend yield, beta, debt-to-EBITDA, market cap. All filters work reliably for US stocks at any market cap level.
Free tier: Full screener, no account required. No time limit. Pro features (watchlists, alerts, saved presets) require an account.
Paid plan: €29/month Pro (~$31/month). Less expensive than Finviz Elite at equivalent functionality for cross-market investors.
Best for: Investors who analyze US stocks alongside European or Canadian equities. Particularly useful for global value investors who compare valuations across markets and need a single consistent screener interface.
Limitations: No technical analysis filters (RSI, chart patterns). Not a charting platform — designed for fundamental screening only.
3. Stock Analysis — Best completely free US screener
Coverage: US equities — NYSE, NASDAQ, NYSE American. Good fundamental data quality for S&P 500 and Russell 2000 components. OTC coverage is lighter.
Filters: Market cap, P/E, P/S, P/B, EV/EBITDA, dividend yield, revenue growth, earnings growth, profit margin, debt-to-equity. Around 30–35 filters — sufficient for most value and growth screening workflows.
Free tier: Fully free, no account required, no filter restrictions. One of the most generous free tiers of any US screener.
Paid plan: No paid plan for the screener. The site monetizes through premium individual stock analysis reports.
Best for: Investors who want a capable US screener at zero cost without account creation. Good for straightforward fundamental screens without technical overlays.
Limitations: No technical filters. Filter depth is below Finviz. No European or Canadian coverage. OTC data can be sparse.
4. Yahoo Finance — Basic, widely used, not systematic
Coverage: US equities, plus global markets. Broad coverage but fundamental data quality for US small caps is inconsistent — particularly below $300M market cap.
Filters: Around 20 filters — market cap, P/E, P/S, EV/EBITDA, dividend yield, earnings date, 52-week price range. Filter updates require page navigation, not real-time results.
Free tier: Free with account. Core screener is usable without paying.
Paid plan: Yahoo Finance Plus at ~$25–35/month adds more data and removes ads.
Best for: Casual investors who want a starting point and are already in the Yahoo Finance ecosystem. Not suited for systematic screening or research-driven workflows.
Limitations: Slow, page-reload-based screener. Filter depth is insufficient for serious screening. Data quality for US small caps is unreliable. Better used for individual stock research than systematic filtering.
5. Zacks — Best for earnings estimate-driven screening
Coverage: US equities — NYSE, NASDAQ. Strong on earnings estimates and earnings revision tracking. Fundamental data quality is generally good for US stocks above $200M market cap.
Filters: Fundamental filters plus Zacks Rank (proprietary earnings estimate revision signal), earnings estimate revisions, earnings surprise history, analyst recommendations. The earnings-estimate layer is genuinely differentiated for investors whose strategy is estimate-driven.
Free tier: Limited. Core screener features are behind a paywall. Basic Zacks Rank lookup is free.
Paid plan: $249/year Zacks Premium ($20.75/month).
Best for: US investors whose strategy incorporates earnings estimate revisions — particularly growth-at-a-reasonable-price (GARP) and momentum investors who want a systematic earnings quality signal. The Zacks Rank has documented predictive value over 3–6 month horizons.
Limitations: No European or Canadian coverage. Not a free option for core features. UX is dated. Less useful for pure value screening where earnings estimates matter less than current fundamentals.
6. TradingView — Best for combining charts and US fundamental filters
Coverage: US equities and global markets including European and Canadian exchanges. Fundamental data for US large and mid-cap stocks is good; small cap data consistency varies.
Filters: Technical-first — RSI, moving averages, volume, chart patterns. Fundamental filters available: P/E, P/S, EV/EBITDA, market cap, dividend yield. Unique in allowing technical and fundamental criteria in one filter pass.
Free tier: Account required. Screener is restricted on the free plan — filter combinations are limited.
Paid plan: $15–60/month depending on tier.
Best for: US investors who drive decisions primarily from charts and want fundamental filters as a secondary check. If your workflow starts with a chart, not a filter table, TradingView is the natural home.
Limitations: Fundamental data for US small caps is less reliable than Finviz. Not optimized for systematic fundamental screening — the screener is secondary to charting. Requires account even for the free tier.
7. TIKR — Best for historical financial depth on US stocks
Coverage: 100,000+ stocks globally including US, Canada, and Europe. Fundamental data quality for US companies is strong, particularly for larger names with long reporting histories. Historical data going back 20 years on Pro.
Filters: Extensive fundamental filters plus 20-year historical financial data per company. Revenue, margins, earnings, FCF, and balance sheet going back two decades is a genuine differentiator for long-term fundamental investors.
Free tier: Freemium with friction. Account required. Core screener is accessible; advanced historical features require paid plan.
Paid plan: ~$10–15/month Plus · $40–55/month Pro.
Best for: Long-term investors who need deep historical financials alongside screening. Ten-year ROIC trends, margin history, and balance sheet evolution are visible for individual stocks — useful for assessing business durability.
Limitations: Not optimized for rapid filter iteration — the UX is research-focused, not screener-focused. More expensive than Finviz on the Pro tier for users who only need US coverage.
US stock screener comparison table (2026)
| Screener | US Coverage | Filter Depth | Technical Filters | Price/mo | Free No-Account |
|---|---|---|---|---|---|
| Finviz | ✓ Full | 65+ | ✓ | $39.50 | Yes |
| ScreenerHero | ✓ Full | 30+ | ✗ | €29 | Yes |
| Stock Analysis | ✓ Full | 30–35 | ✗ | Free | Yes |
| Yahoo Finance | Partial | ~20 | Limited | $25–35 | Partial |
| Zacks | ✓ Full | 30+ earnings | ✗ | $20.75 | No |
| TradingView | ✓ Full | 25+ | ✓ | $15–60 | No |
| TIKR | ✓ Full | 40+ | ✗ | $15–55 | No |
Data as of June 2026.